The new indication allows durvalumab, in combination with carboplatin and paclitaxel, to be used as a first-line treatment ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

The 76-year-old, last month, revealed he has been diagnosed with skin cancer for the 'second time in three years' and has ...

Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the 'Company”), a late-stage clinical biopharmaceutical company focused on the ...

Gut health may play a crucial role in protecting us from the harmful effects of PFAS – toxic and long-lasting "forever ...

Oncternal could receive up to $65 million in milestones if the programs are successful. Regulatory events account for $40 ...

In the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...

Funding cuts and sky-high inflation have made researchers in Argentina thrifty and creative. What can U.S. colleagues learn ...

On Friday, June 27, the American Lung Association honored Pfizer with the Outstanding Corporate Partner Award at its annual awards celebration in Chicago for their long-standing commitment, leadership ...

During a rundown of royal finances, one of the King's key aides revealed how the monarch is tackling his royal duties as he continues his cancer treatment ...